Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP

* Subject must be older than 18 years. * If the subjects are under pharmacological treatments, there must be no variations on the medicament dosages for at least one month (steady consumption). * The last session of previous treatments must be at least 3 months old. * Any pain reduction potentially attributed to previous phantom limb pain treatments must be at least 3 months old. * Subjects must have control over at least a portion of biceps and triceps muscles for upper limb amputations, and quadriceps and hamstrings for the lower limb amputations. * The subject has signed a written informed consent. * The subject must be in a stable prosthetic situation (i.e. satisfied with the fitting of the prosthesis) or being a non user. * At least six months should be passed since the amputation: acute phantom limb pain cases should not be included in the study. * The patient subject should not have a significant cognitive impairment that prevents the patient from following instructions. * Subjects with abundant soft tissue on their stump will not be automatically excluded, however, an evaluation in the system is required to analyze if sufficient electromyography signals can be recorded. * Subjects for whom skin contact or muscle contraction are painful (NRS \> 2) are not eligible for the study. * The subject should not have any condition associated with risk of poor protocol compliance. * The subject should not have any other condition or symptoms preventing the patient from entering the study, according to the investigator´s judgement.